Aldosterone synthase inhibitor is a highly anticipated drug in cardio-metabolic indication. Future drug will selectively inhibit synthesis of aldosterone .

Wу are targeting a mycobacterial cytochromes P450, responsible for cell wall formation and depression of local immune response in human., for treatment of resistant (MDR, XDR) forms of tuberculosis. 

Separate progect serving to improve our technological platform, combined with pipeline extension and scientific collaborations activities